dreamm-2: belantamab mafodotin for r/r myeloma
Published 3 years ago • 128 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
0:48
final analysis of the dreamm-2 trial: belantamab mafodotin for r/r multiple myeloma
-
8:05
dreamm-2: belantamab mafodotin for r/r mm
-
1:59
dreamm-2: update on belantamab mafodotin in r/r myeloma
-
0:58
belantamab mafodotin: a potential new soc in second-line myeloma based on the dreamm trials
-
6:09
dreamm-2: effects of belantamab mafodotin on patient reported outcomes in myeloma
-
1:32
the use of belantamab mafodotin in triplet combinations for multiple myeloma
-
7:57
updates on dreamm-6 and dreamm-2 in r/r myeloma
-
0:58
improving the long-term safety of cll treatment
-
4:38
the potential of mrd-adapted treatment in multiple myeloma
-
2:55
the addition of bortezomib to melphalan-based conditioning in multiple myeloma
-
9:42
progress report i - jázmin németh
-
2:15
results of dreamm-4: safety and efficacy of belantamab mafodotin with pembrolizumab in r/r myeloma
-
5:15
dreamm-2 & dreamm-5: belantamab mafodotin for myeloma
-
3:04
dreamm-3: belantamab mafodotin vs pom/dex for r/r myeloma
-
1:40
dreamm-2: post-hoc analysis of 2.5mg/kg cohort of belantamab mafodotin for myeloma
-
1:44
the role of belantamab mafodotin in multiple myeloma: the dreamm-7 and dreamm-8 trials
-
3:17
the promise of belantamab mafodotin for the treatment of multiple myeloma
-
0:58
patient-reported outcomes from the dreamm-8 trial of belantamab mafodotin in multiple myeloma
-
4:40
management of ocular events in patients treated with belantamab mafodotin plus pomdex in dreamm-8
-
1:02
dreamm-3: safety of belantamab mafodotin versus pom/dex in patients with r/r myeloma
-
3:00
results of a phase i study of belantamab mafodotin in combination with krd for treating myeloma